Intermountain Healthcare, Stanford Cancer Institute, Providence St. Joseph Health, and Syapse joined together today to announce a new consortium to advance cancer care through data sharing and increase access to clinical trials. Responding to Vice President Joe Biden’s Cancer Moonshot Initiative, the Oncology Precision Network (OPeN) will share, as appropriate, aggregated cancer genomics data through an advanced software platform, rapidly bringing the most promising treatment insights to cancer patients and physicians.
This unprecedented collaboration between two of the nation’s largest not-for-profit health systems, one of the country’s premiere academic research centers, and Syapse, a leading precision medicine software company, aims to find breakthroughs in cancer care by leveraging previously untapped real-world cancer genomics data while preserving privacy, security, and data rights.
OPeN will provide access to precision medicine and clinical trials for previously underserved cancer patients. The vast majority of cancer patients are not treated by major cancer centers and don’t benefit from high volume based analytics. OPeN will help extend this knowledge to communities across the country.
The OPeN members anticipate an immediate 100,000 data sets in the OPeN database. When fully implemented, OPeN will impact 50,000 new cancer patients per year, representing three percent of the nation’s total; 200,000 total cancer patients per year; and have more than 1.5 million historical cancer cases. OPeN comprises data and physicians across 11 states, 79 hospitals and 800 clinics. OPeN hopes to include other health systems later in the year, with the long-term goal of impacting cancer care across the United States.